Visible Hydrogels For Rapid Hemorrhage Control and Monitoring

December 21, 2020
(LOS ANGELES) – There are many different events which may lead to excessive and uncontrolled bleeding within the body. This can occur as a result of inflammation and ulcerations, abnormalities in the blood vessels or trauma-related injuries. Individuals with predisposing conditions, such as cardiac patients, are at particular risk of internal bleeding due to the anticoagulants they are often prescribed as a preventive measure. They are also prone to gastrointestinal bleeds, affecting 40% of patients who are on cardiac assistance devices. In addition to the need for an effective treatment for these conditions, there are also indications for controlling the blood flow that contribute to aneurysms and tumor cell vascularization.

TREC, TIBI, & One Lambda Inc. Launch Mass Media Campaign to Promote Living Donation

November 25, 2020

The Transplant Research and Education Center (TREC), in partnership with the Terasaki Institute for Biomedical Innovation and One Lambda Inc., on October 21st launched a 6-month mass media campaign to raise awareness about the Living Donation Storytelling Project. The campaign seeks to reach kidney and transplant patients, living donors, and nephrology, dialysis, and transplant professionals across the nation to help them learn about the innovative educational resources available through the Living Donation Storytelling Project. The Living Donation Storytelling Project is an online digital library of video stories recorded by real living donors, recipients, family members, and those in need of a kidney.

Television and Medicine: Patients, Donors, and Medical Professionals Respond to New CBS Sitcom about Living Donation

November 20, 2020

On November 5th, five million people watched the premiere of a new CBS show about living donation! B Positive is a new comedy sitcom following one man’s living donation journey. Drew, a therapist and single dad, is shocked to find out his kidneys are failing and he’s in urgent need of a transplant. With a rare blood type and lacking friends or family to ask to be his donor, Drew feels hopeless until he runs into an old high school acquaintance—Gina. Gina spontaneously offers to be his donor in her quest to do something bigger than herself.  

The busts of 5 laureates of the 2019 Mustafa Prize Laureates’ Busts Unveiled in Tehran

November 2, 2020
The busts of 5 laureates of the 2019 Mustafa Prize were unveiled with the presence of 3 laureates
Observing the health protocols to prevent the spread of COVID-19, during a ceremony held on November 1, 2020, the busts of the 2019 Mustafa Prize laureates, Ali Khademhosseini, Ugur Sahin, Umran S. Inan, Hossein Baharvand, and Mohammad Abdolahad were unveiled in the Scientists’ Garden, Pardis Technology Park.
A Heart-Breast Cancer-on-a-Chip Monitoring System

October 26, 2020

Dual-organ system enables the measurement of cardiac toxicity arising from breast cancer chemotherapy 

(LOS ANGELES)  Breast cancer is the most commonly occurring cancer for women around the world, and much effort has been spent in the development of therapies to treat this disease. Among these treatments, chemotherapy has been shown to be among the most effective methods; however, the drugs used in these therapies can have adverse side effects, the most serious of which is toxicity to the heart.  In addition to tissue damage to the heart, chemotherapeutic breast cancer drugs can also affect the heart’s pumping ability or result in clinical heart failure. 

TREC Awarded First Place ClearMark Award for COVID-19 Patient Guide by the Center for Plain Language

October 26, 2020

The Transplant Research and Education Center (TREC) and Health Literacy Media have received the first-place ward in the Special COVID-19 Category at the 2020 ClearMark Awards for Doing everything you can during COVID-19, a comprehensive educational guide for kidney and transplant patients. The ClearMark Awards is an annual event hosted by the Center for Plain Language that celebrates achievements in plain language communications by companies, governments, and organizations across North America. Winners are invited to include the ClearMark stamp on their communications materials, signaling the highest standard for clarity and simplicity. 

Announcing the Launch of a National Campaign to Capture Stories of Hope and Transformation through Living Donation

October 26, 2020 

The Transplant Research and Education Center (TREC) and the Terasaki Institute for Biomedical Innovation, with support from Thermo Fisher Scientific, announce the kickoff of a campaign to capture stories of hope and transformation through the Explore Living Donation Storytelling Project. 

(LOS ANGELES) - The Transplant Research and Education Center (TREC), in partnership with the Terasaki Institute for Biomedical Innovation and One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of in vitro diagnostic products for the HLA transplant community, has launched a six-month mass media campaign for kidney and transplant patients, living donors, and medical providers to raise awareness about the innovative resources available through the Living Donation Storytelling ProjectThe campaign aims to capture the stories of 500 living donors and inspire, educate and promote living donor kidney transplant (LDKT) 

Wearable Pressure-Sensitive Devices for Medical Use

October 16, 2020

Novel design and strategic use of materials in a pressure-sensitive adhesive strip

(LOS ANGELES) – In recent years, the use of wearable sensing devices has become a part of people’s everyday lives.  Devices such as smart watches, for example, can be used to monitor physical fitness functions such as heart rate, sleep and exercise. 

But advances in technology have opened many more possibilities for monitoring patient health.  Sensors can now measure important health indicators such as metabolites, oxygen or therapeutic drug levels in the blood using wearable or hand-held devices.  This allows patients an easy method of performing continuous, less invasive, real-time testing at home for diagnostic or treatment purposes.  Having such a system profoundly impacts both patient and caregivers’ needs, decreasing the requirement for frequent hospital appointments and encouraging compliance with treatment.